Authors



James Blackmer, PharmD, MPA, MS

Latest:

Fostering Rapid Innovation During a Time of Crisis

Promoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.



Erin Albert, PharmD, JD, MBA

Latest:

The Career Game Changers of Pharmacy

Which game will your pharmacy career resemble: Risk, Cranium, Chutes and Ladders, or Candy Land?


Daksha Potnis, PharmD

Latest:

Drug-Induced Liver Injury in Children: Atomoxetine and Nonstimulants for ADHD

Mechanisms of drug-induced liver injury in children, case reports of atomoxetine-induced liver injury in children, and nonstimulant options for attention-deficit/hyperactivity disorder.


Alexandra Coults, PharmD Candidate

Latest:

Prescriptions for Man, and Man's Best Friend

Veterinary pharmacy is a difficult field. Pharmacists must judge if the prescribed dose is appropriate for the pet, based upon age, gender, species, and indication.


Joseph Adelufosi, PharmD Candidate

Latest:

Breast Cancer: the Clinician's Involvement

For many women, the fear of breast cancer is always present.


Tim Davis, Beaver Health Mart Pharmacy

Latest:

2010 Technology Innovator of the Year: Tim Davis

2010 Technology Innovator of the Year Tim Davis is plugged in, and uses technology every day to help patients and run his business more efficiently.


Tracey Ryan

Latest:

Managed Care Biologics and Injectables

Payer response to new entrants to the multiple sclerosis (MS) market is mixed as some believe that there remain meaningful, major unmet needs in the MS category, according to The Zitter Group's Spring 2011 Managed Care Biologics and Injectables Index.




Beena Kuriakose, PharmD

Latest:

Private-payer Costs for Employees with Treatment-resistant Depression

Individuals with treatment-resistant depression do not achieve and sustain remission after multiple pharmacotherapies, with an unknown impact on employment. This study investigates the expenditures of TRD from a private-payer perspective in Canada.


Sharon Cherian, PharmD Candidate

Latest:

Dolutegravir Is Susceptible to Chelation-Type Interactions

Common medications containing polyvalent cations should be separated to prevent decreased absorption of the HIV therapy.


James Price, MD

Latest:

Patients With Pain Benefit From a Multimodal Approach

This method may optimize pain control and could be an answer to the opioid crisis.


Christa Eans, PharmD, AAHIVP, MSPBA Candidate

Latest:

Biosimilars Action Plan: There's No Better Time Than Now

Several hurdles remain for biosimilars to flourish in the US market.


Glen Pietrandoni, RPh, AAHIVP

Latest:

HIV-Positive Patients with Comorbidities Benefit from Personalized, Pharmacist-Led Care

HIV-specialized pharmacies meet the complex needs of HIV-positive patients, helping to provide comprehensive patient care and improve medication adherence to both anti-retroviral therapies and non-HIV medications.


Kelly Johnson

Latest:

After Doughnut Hole Closure, Oral Anticancer Drug Costs Still Too High for Many

Study finds that patients prescribed expensive drugs will continue to face high out-of-pocket costs.


Kimberly Hicks, PharmD, MHA

Latest:

Focus on Hepatitis C: Bridging the Gap from New Drug Therapy to Successful Treatment

Specialty pharmacists can help patients achieve successful outcomes in the treatment of hepatitis C by providing comprehensive clinical consultations on triple therapies.



Keith Bailey

Latest:

Connecting the Dots for a Digital Deploy: A Guide to Engaging Pharma Stakeholders

Strategic tips for pharma to develop an overall business strategy around digital engagement.



Lydia Chou, PharmD

Latest:

Identifying and Managing Fungal Skin Infections

Moist, warm skin provides the ideal environment for dermatophytes—fungi that cause skin infections—to flourish.




Woodie M. Zachry III, PhD, RPh

Latest:

Statin-Fenofibrate Combination Therapy in an ACCORD Population: A Retrospective Analysis

Retrospective analysis of a population meeting criteria for the ACCORD lipid trial supported adjunct fenofibrate in patients with reduced low-density lipoprotein cholesterol and elevated triglycerides.




Evan Lantz, PharmD

Latest:

Passing the First Test: How to Impress on the Residency Interview

With more and more students applying for residency positions, off-site interviews are becoming an important first step in the selection process.



Jerry A. Barbee Jr, PharmD, BCPS, CPh

Latest:

Explore Ovarian Cancer Treatments Through Clinical Trials

Guidelines typically recommend debulking surgery, plus systemic chemotherapy for most patients.

© 2024 MJH Life Sciences

All rights reserved.